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Abstract
Background: Tetanus remains common in many low- and middle-income countries, but as critical care services improve,
mortality from tetanus is improving. Nevertheless, patients develop severe syndromes associated with autonomic nervous
system disturbance (ANSD) and the requirement for mechanical ventilation (MV). Understanding factors associated with
worse outcome in such settings is important to direct interventions. In this study, we investigate risk factors for disease
severity and long-term physical outcome in adults with tetanus admitted to a Vietnamese intensive care unit.
Methods: Clinical and demographic variables were collected prospectively from 180 adults with tetanus. Physical function
component scores (PCS), calculated from Short Form Health Survey (SF-36), were assessed in 79 patients at hospital
discharge, 3 and 6 months post discharge.
Results: Age, temperature, heart rate, lower peripheral oxygen saturation (SpO2) and shorter time from first symptom to
admission were associated with MV (OR 1.03 [ 95% confidence interval (CI) 1.00, 1.05], p = 0.04; OR 2.10 [95% CI 1.03, 4.60],
p = 0.04; OR 1.04 [ 95% CI 1.01, 1.07], p = 0.02); OR 0.80 [95% CI 0.66, 0.94], p = 0.02 and OR 0.65 [95% CI 0.52, 0.79, p <
0.001, respectively).
Heart rate, SpO2 and time from first symptom to admission were associated with ANSD (OR 1.03 [95% CI 1.01, 1.06], p <
0.01; OR 0.95 [95% CI 0.9, 1.00], p = 0.04 and OR 0.64 [95% CI 0.48, 0.80], p < 0.01, respectively).
Median [interquartile range] PCS at hospital discharge, 3 and 6 months were 32.37 [24.95–41.57, 53.0 [41.6–56.3] and 54.8
[51.6–57.3], respectively. Age, female sex, admission systolic blood pressure, admission SpO2, MV, ANSD, midazolam
requirement, hospital-acquired infection, pressure ulcer and duration of ICU and hospital stay were associated with reduced
0.25 quantile PCS at 6 months after hospital discharge.
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Conclusions: MV and ANSD may be suitable endpoints for future research. Risk factors for reduced physical function at 3
months and 6 months post discharge suggest that modifiable features during hospital management are important
determinants of long-term outcome.
Keywords: Tetanus, Clostridium tetani, Tetanus toxin, Acute critical illness, Vietnam, Low-income and middle-income
countries (LMICs), Severity, Long-term outcome, Physical function
Background
Tetanus is a vaccine-preventable disease associated with
severe muscle spasm and cardiovascular system disturb-
ance that remains a common cause of acute critical ill-
ness in low- and middle-income countries (LMICs) [1].
As critical care services improve throughout the world,
the capacity to manage severe tetanus is increasing and
some centres have reported significant reductions in
mortality rates [2–4]. Nevertheless, patients still experi-
ence severe muscle spasms necessitating prolonged
treatment with muscle relaxants and mechanical ventila-
tion in addition to cardiovascular instability and auto-
nomic nervous system dysfunction (ANSD) [5].
Historical literature contains many studies documenting
risk factors for mortality in tetanus when muscle spasm
were the principal causes of death [6, 7]. It is unclear
whether these same risk factors are important in modern
ICU settings where death due to respiratory muscle
spasms can be prevented by mechanical ventilation [5, 8].
Furthermore, as mortality rates decrease, predicting those
at risk of other outcomes such as mechanical ventilation
or ANSD may be more relevant to everyday clinical prac-
tice and clinical trial outcomes [9, 10].
As survivorship improves, understanding the quality of
life of survivors is increasingly important but is much
neglected in published literature, particularly in LMIC set-
tings. There is very little known about disability in tetanus
survivors although this is particularly important as in most
countries tetanus affects mainly men of working age
where long-term disability might have a significant social
and economic impact. The limited data that do exist sug-
gest a significant number of survivors are left with impair-
ment. In a retrospective study of adults with tetanus
admitted to intensive care units (ICUs) in France, out of
38 survivors with a known functional status at follow-up,
39% suffered worsening of functional impairment com-
pared to before admission, whilst 17% required admission
to a long-term care facility [11]. In a Japanese case series,
35% of all survivors were discharged from hospital to a fa-
cility other than home [12]. Muscle wasting has been
identified as an important factor contributing to ICU-
related functional impairment [13]. We have previously
reported significant muscle wasting during hospitalisation
in adults with tetanus, the degree of which was related to
age, occurrence of hospital-acquired infection, and subse-
quent health-related quality of life scores [14].
We examine what factors predict more severe disease
and also what factors are associated with physical
disability at hospital discharge, 3 and 6 months post
hospital discharge. This information is an important step
to improving tetanus outcome in other centres and under-
standing more about long-term effects of critical illness in
low- and middle-income countries.
Methods
The study was performed at the Hospital for Tropical
Diseases (HTD), Ho Chi Minh City. The hospital is a
tertiary referral centre for infectious diseases serving
Southern Vietnam. Patients were treated according to a
standard protocol as previously described [15]. Briefly,
this consists of antibiotics and antitoxin; spasm control
with benzodiazepeines (midazolam or diazepam) esca-
lated to non-depolarising muscle relaxants (pipecuro-
nium) and mechanical ventilation. Airway management
is by primary tracheostomy with the following indica-
tions: laryngeal spasms compromising the airway, spu-
tum retention and to facilitate mechanical ventilation.
ANSD is managed with magnesium sulphate and add-
itional calcium antagonists or inotropes as clinically in-
dicated. All patients receive a full primary course of
tetanus-toxoid containing vaccine initiated at discharge.
ANSD was defined as at least 3 of (i) heart rate > 100
beats per minute (bpm), (ii) systolic blood pressure >
140 mmHg, (iii) mean arterial pressure < 60 mmHg,
(iv) pyrexia > 38 °C, and (v) fluctuating blood pressure,
occurring within one day with no other apparent
cause [16].
Investigation of risk factors for tetanus severity was
carried out with prospectively collected data from two
cohorts of patients ≥ 16 years old admitted to the hospi-
tal’s ICU with a diagnosis of generalised tetanus: from
August 2016 to March 2017 and January to July 2018,
described elsewhere [14]. Physical functional outcome
was evaluated in the subgroup of patients enrolled be-
tween August 2016 and March 2017 in whom there
were 2 exclusion criteria: not speaking Vietnamese and
unable to walk before admission. The Study Flowchart is
shown in Additional File 1.
Data were collected prospectively daily by study staff
in all enrolled subjects. A core dataset of recognised tet-
anus prognostic features, basic clinical and demographic
data were collected in both cohorts Additionally patients
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were followed daily for complications and interventions
such as MV by study staff. Treatment for hospital-
acquired infections of ventilator-associated pneumonia,
urinary tract infection and bacteraemia were specifically
evaluated in these daily observations. Diagnosis and
treatment of these followed local hospital guidelines. In
the physical outcome subgroup, physical function was
assessed using the physical component summary score
(PCS) derived from the RAND 36-item Short Form
Health Survey (SF-36) version 1 completed at hospital
discharge by face-to-face interview, 3 months post dis-
charge and 6 months post discharge by telephone inter-
view [17]. Using the method described by Ware et al.,
individual question scores were transformed and aver-
aged to the eight aggregate scale (domain) scores and,
from these, the PCS was calculated [18]. This method
results in a single PCS for each patient, calculated by dif-
ferentially weighting then combining the scale scores
and applying a linear transformation. Applying this
methodology to the US population data results in a
mean PCS of 50 with a standard deviation of 10. Stand-
ard US scores were used for PCS calculation as no vali-
dated Vietnamese population standard scores exist.
Statistical analysis
Descriptive statistics were used to describe the sample with
the median and interquartile range (IQR) for continuous
data, and count and percentage for categorical data.
Univariate logistic regression was used to examine associa-
tions between ANSD and each of the demographic and
baseline clinical features. Features were selected based on
the availability in the core dataset (i.e. both cohorts of
patients) and clinical plausibility associated with known
prognostic indicators in tetanus. Baseline features selected
were age, gender, entry site, incubation period, period of
onset, time from first symptom to first spasm and symptom
of difficulty breathing on admission. Clinical features on ad-
mission were taken as the worst value in the first 24 h:
highest heart rate, heart rate range, maximum systolic
blood pressure and temperature, peripheral oxygen satur-
ation (SpO2), serum creatinine, platelet count, white blood
cell count, urine output and Ablett score. Briefly, Ablett
scores the severity of tetanus according to spasms (grade 1
no spasms, 2 mild spasms, 3 spasms interfering with respir-
ation) and additional clinical autonomic disturbance (grade
4) [19]. Variables that were associated with ANSD in the
univariate analysis were entered into a multivariate logistic
regression model using a backward approach dropping one
least significant variable at a time. A backward approach
was selected due to the large number of potential covariates
and to reduce issues related to multiple collinearity. The
major assumptions of logistic regression including the lin-
earity assumption, multicollinearity and influential values
were checked for the models.
The same strategy as outlined above was used to
evaluate risk factors for MV but given the independent
variables being used to predict the requirement for MV
included baseline clinical features recorded during the
first 24 h of ICU admission, those patients who were also
mechanically ventilated during the first 24 h of admis-
sion were excluded from this univariate and multivariate
logistic regression analysis.
Prior to analysis by linear regression, the PCS at hos-
pital discharge was graphed as a histogram and quantile-
quantile (Q-Q) plot to assess the distribution of residuals
and validate suitability for linear regression analysis.
Simple linear regression was used to examine the de-
pendency of PCS at hospital discharge by each of the in-
dependent variables in the dataset. Multiple linear
regression was then used to model variables associated
with PCS at hospital discharge. Variables that were iden-
tified to be significantly associated with PCS at hospital
discharge in analysis by simple linear regression were all
entered into the model using a backwards approach,
dropping one least significant variable at a time. The
model was then verified using a forward approach by
introducing the variables sequentially. The distribution
of the PCS at 3 months and 6 months post discharge
were very skewed (Shapiro-Wilks normality tests p
values < 0.000001 for 3 month and 6 month PCS) with
mode values at the extreme of the range. Linear quantile
was therefore used for analysis as this, unlike parametric
methods, makes no assumptions about the distribution
of the residuals. Using this method, the effect of inde-
pendent variables on admission to ICU and features dur-
ing ICU management were modelled on each specified
quantile of 0.25, 0.5 and 0.75 (i.e. 1st quartile, median
and 3rd quartile) of the respective dependent variables:
3-month post discharge PCS, and 6-month post dis-
charge PCS. The threshold for significance was p ≤ 0.05
(two-tailed). All analyses were carried out in Stata (Stata-
Corp) version 16 and R Version 4.0.2 (R Corporation,
Vienna).
This study was approved by the London School of
Hygiene and Tropical Medicine (LSHTM) ethics com-
mittee, the Oxford Tropical Medicine Ethics Commit-
tee (OxTREC) and the local HTD ethics committee.
All participants gave written informed consent prior
to enrolment.
Results
One hundred eighty patients aged between 17 and 98
years, with generalised tetanus, were included in this
study. A summary of the baseline features of the patients
are described in Table 1. Ninety of 180 (50%) required
MV for a median duration of 16.0 [IQR 12–24] days
(Additional Files 1 & 2).
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Associations of admission features with disease severity
After removing the 16 patients who were mechanically
ventilated during the first 24 h of admission (including 2
patients who died), data from 164 patients were available
for analysis, of whom 74 (45.1%) patients required MV
and 3 (1.8%) died. The features on ICU admission asso-
ciated with MV after 24 h admission in univariate ana-
lysis are shown in Table 2.
Multivariate logistic regression analysis showed that
the following admission variables were associated with
increased odds of requiring MV: increased age (OR 1.03,
95% CI 1.00–1.05, p = 0.04), temperature (OR 2.10, 95%
CI 1.02–4.58, p = 0.04) and HR (OR 1.04, 95% CI 1.01–
1.07, p = 0.02); and lower SpO2 (OR 0.80, 95% CI 0.66–
0.94, p = 0.02) and shorter time from first symptom to
admission (OR 0.65, 95% CI 0.52–0.79, p < 0.001).
Analysis of features present at ICU admission and as-
sociated with the development of the ANSD was per-
formed on data from 177 participants after removing 1
patient with ANSD on admission to ICU and 2 patients
with missing data. In this group, 43 (24.3%) developed
ANSD. The features present at ICU admission and
associated with the development of ANSD in univariate
analysis after excluding the one patient who had ANSD
on admission are shown in Table 3.
Multivariate analysis showed similar admission fea-
tures were associated with the development of ANSD as
with MV. There was strong evidence of an association
between the development of ANSD with time from the
first symptom to admission (OR 0.64, 95% CI 0.48–0.80,
p < 0.01) and maximum HR during the first day of ad-
mission (OR 1.03, 95% CI 1.01–1.06, p = 0.004). There
was some evidence of an association between SpO2 on
admission to ICU and development of ANSD (OR 0.95,
95% CI 0.90–0.10, p = 0.04).
Physical functioning at discharge
Eighty patients with generalised tetanus admitted to the
ICU at HTD between August 2016 and June 2017 had a
physical function at discharge data available and were in-
cluded in the subgroup analysis. The median [IQR] PCS
at hospital discharge was 32.37 [24.95–41.57].
The association of independent admission features
with PCS at hospital discharge are shown in Additional
File 3. Independent admission features associated with
PCS at hospital discharge include age, female sex, pres-
ence of comorbidities, platelet count and HR during the
first 24 h of admission. The association of independent
features during ICU admission with PCS at hospital
discharge are shown in Additional File 4. Independent
Table 1 Description of the demographic and clinical features of tetanus patients on admission to ICU
Physical outcome cohort (N = 80) All (n = 180)
Parameter Median [IQR] or count (%) Median [IQR] or count (%)
Demographics
Age (years) 49.0 [35.0–59.5] 51.0 [40.5–62.0]
Male sex 64 (80.0%) 143 (79.4%)
Coexisting comorbidities 22 (27.5%) 73 (40.6%)
Tetanus specific features
Deep wound 2 (2.5%) 5 (2.8%)
Incubation period (days) 8 [6–11] 8 [7–13]
Onset period (h) 48 [24–72] 48 [24–72]
Time from first symptom to admission (days) 3 [2–5] 3 [2–5]
History of difficulty breathing 16 (20.0%) 37 (20.6%)
Clinical features during first 24 h of admission
Highest systolic blood pressure (mmHg) 130 [120–140] 140 [130–150]
Highest heart rate (bpm) 90 [82–98] 93 [84–104]
Highest temperature (°C) 37.0 [37.0–37.5] 37.5 [37.0–38]
SpO2 on admission (%) 97 [96–98] 97 [95–98]
Ablett score:*
1 17 (21.3%) 36 (20%)
2 49 (61.3%) 116 (64.4%)
3 13 (16.3%) 27 (15%)
4 1 (0.6%) 1 (0.6%)
*Ablett score: Grade 1 no spasms, grade 2 mild spasms not interfering with respiration, grade 3 spasms interfering with respiration and grade 4: grade 3 with
clinical signs of autonomic nervous system dysfunction [19]
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variables significantly associated with PCS at hospital
discharge included the requirement for tracheostomy
and duration of tracheostomy requirement, requirement
for MV, development of ANSD, development of any
HAI, duration of ICU admission and duration of hospital
admission.
The features associated with PCS at hospital discharge
in the multiple regression analysis were age (β − 0.20,
95% CI − 0.31, − 0.09, p < 0.001), duration of ICU ad-
mission in days (β − 0.22, 95% CI − 0.40, − 0.05, p =
0.01) and the development of at least one HAI (β − 4.62,
95% CI − 9.26, 0.02, p = 0.05).
Physical functioning at 3 and 6 months
Median PCS at 3 months and 6 months post discharge
were 53.0 [IQR 41.6–56.3] and 54.8 [IQR 51.6–57.3], re-
spectively. Features associated with PCS in participants
in the lowest functioning quantile (0.25) are shown in
Tables 4 and 5. Admission features of the female sex,
age, SpO2 and highest systolic blood pressure were sig-
nificantly associated with PCS at 6 months post dis-
charge in this quantile. Management features strongly
associated with PCS at 6 months after discharge in the
lowest quantile PCS included MV, development of
ANSD, development of HAI, bacteraemia, ventilator-
associated pneumonia, pressure ulcer, length of ICU and
hospital stay (Table 5).
In those with highest quantile PCS (0.75 quantile),
ventilator-associated pneumonia was associated with
reduced PCS at both 3 and 6 months after hospital dis-
charge (β − 3.32 [95% CI − 0.34, 0.00], p = 0.002; β −
2.61 [95% CI − 2.61, 18.00], p < 0.001, respectively), and
female sex at 6 months (β − 5.20 [95% CI − 5.57, −
3.21], p = 0.04).
Discussion
We present data from a large contemporary series of pa-
tients with tetanus. Despite low mortality rates, our pa-
tients required long periods in ICU and developed
severe tetanus with respiratory compromise and ANSD.
Risk factors identified for these were similar to those
previously identified for mortality [6, 21]. Whilst some
variables such as SpO2, were novel, dyspnoea noted by
admitting doctors is a recognised prognostic feature and
we believe SpO2 represents a more objective measure of
respiratory compromise [21]. The similarity between the
Table 2 Tetanus risk factors for mechanical ventilation (n = 164)
Parameter No MV (n = 90) MV (n = 74) OR for MV 95% CI P value
Median [IQR], mean
(±SD) or count (%)
Age (years) 46 [37–59] 52.5 [43–65] 1.027 1.01–1.05 0.01
Male sex 72 (80.0%) 60 (81.1%) 1.07 0.49–2.36 0.86
Any comorbidities 30 (33.3%) 34 (45.9%) 1.70 0.90–3.22 0.10
Deep wound 2 (2.2%) 2 (2.7%) 1.22 0.14–10.39 0.84
Incubation period (days) (n = 122) 10 [7–14] 8 [6–11] 0.99 0.952–1.04 0.78
Period of onset (h) (n = 141) 48 [24–72] 48 [24–48] 0.98 0.97–0.99 0.004
Time from first symptom to admission
(days) (n = 162)
4 [3–6] 3 [2–4] 0.74 0.62–0.86 < 0.001
History of difficulty breathing 10 (11.1%) 19 (25.7%) 2.76 1.22–6.62 0.02
Clinical Features during first 24 h of admission
Highest SBP (mmHg) 136 [120–150] 140 [130–147.5] 1.01 0.99–1.03 0.38
Highest heart rate (bpm) 90 [82–99.5] 97 [88–111.5] 1.05 1.03–1.08 < 0.001
Heart rate range (bpm) 12 [8–20] 16 [10–26] 1.05 1.02–1.08 0.001
Highest temperature (°C) 37.4 [37.0–37.6] 37.5 [37.0––38.0] 2.35 1.36–4.28 0.003
SpO2 (%) 97 [96–98] 96 [94–97] 0.82 0.700–0.93 0.01
SOFA* score = 0 83 (92.2%) 52 (70.3%) Ref.
SOFA* score > = 1 7 (7.8%) 22 (29.7%) 5.02 2.09–13.45 0.001
Urine output (ml/h) 69.7 [42.2–125.5] 76.6 [42.9–113.3] 1.00 0.10–1.00 0.81
Creatinine (μmol/L) 78.9 (± 16.4) 90.9 (± 48.4) 1.01 1.00–1.03 0.04
Platelets (× 109/L) 283.6 (± 81.7) 282.8 (± 97.4) 1.00 1.00–1.00 0.96
Potassium (mEq/L) (n = 94) 3.6 (± 0.4) 3.7 (± 0.6) 1.59 0.72–3.75 0.27
White blood count (× 109/L) (n = 95) 9.6 [7.1–11.0] 10.2 [8.4–13.0] 1.15 1.02–1.34 0.04
*Sequential organ failure score [20]. Descriptive statistic describe number of patients with SOFA score = 0 (reference) or > = 1
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risk factors we have identified and those identified for
mortality supports their use as alternative markers of
disease severity or study end-points in settings such as
ours where mortality is low [22].
Our study is limited by the risk factors available for
consideration, and sample size to look at smaller sub-
populations. Data selection was based on published lit-
erature, including a large case series previously at our
hospital. It is possible therefore that important factors
were not identified or simplified markers. For example,
we used a simple classification of wounds as superficial
or deep based on a previous case series of 100 patients
in our centre (3). Additionally, we have not included fac-
tors such as possible vaccination history. No patients re-
ported knowledge of receiving tetanus vaccination and
anti-tetanus toxoid antibodies from patients in the 2018
cohort were measured and shown to be sub-protective
(reported elsewhere) but it is possible that some patients
may have received some previous immunisation in in-
fancy and had low (sub-protective) antibody levels. The
Expanded Programme on Immunization was introduced
into Vietnam in 1981, and since 1994 has consistently
reported high coverage (90–99%) for DTP3 Similarly
89–93% for maternal vaccination [23]. It is therefore
possible that particularly the younger patients may have
received vaccination in infancy.
Our data on physical function at hospital discharge, 3
months post discharge and 6 months post discharge
demonstrates that most of this relatively young and
middle-aged population regains normal functioning after
a severe illness has resolved. We identified age and pro-
longed hospital stay as the principal indicators of worse
physical functioning at hospital discharge with HAI non-
significantly associated. In those with the lowest PCS
measures 6 months post hospital discharge many factors
were significantly associated with reduced physical
Table 3 Tetanus risk factors for development of ANSD (n = 179)
Parameter No ANSD (n = 135) ANSD (n = 44) OR for ANSD 95% CI P value
Median [IQR], mean
(± SD) or count (%)
Age (years) 49 [40–61] 52.5 [45–68.5] 1.02 0.10–1.04 0.08
Male sex 108 (80%) 35 (79.5%) 0.97 0.429–2.37 0.95
Any comorbidities 51 (37.8%) 21 (47.7%) 1.50 0.75–3.00 0.24
Deep wound 3 (2.2%) 1 (2.3%) 1.02 0.05–8.23 0.98
Incubation period (days) (n = 134) 10 [7–14] 7 [5–10] 0.10 0.95–1.04 0.83
Period of onset (h) (n = 156) 48 [24–72] 24 [24–48] 0.98 0.96–0.99 0.004
Time from first symptom to admission (days) (n = 177) 4 [3–5] 2 [2–3] 0.69 0.54–0.85 0.001
History of difficulty breathing 23 (17.0%) 14 (31.8%) 2.27 1.03–4.92 0.04
Clinical Features during first 24 h of admission
Highest SBP (mmHg) 140 [125–150] 140 [130–150] 1.02 1.00–1.04 0.02
Highest heart rate (bpm) 92 [84–100] 96 [88–120] 1.03 1.01–1.05 0.002
Heart rate range (bpm) 14 [8–22] 16 [10–28] 1.02 0.99–1.05 0.06
Highest temperature (°C) 37.4 [37–37.8] 37.5 [37.2–38.0] 1.46 0.850–2.49 0.16
SpO2 (%) 97 [96–98] 96 [93–98] 0.96 0.90–1.00 0.08
SOFA score:
0 115 (85.2%) 31 (70.5%) Ref.
> = 1 20 (14.8%) 13 (29.5%) 2.41 1.06–5.36 0.03
Urine output (ml/h) 71 [43–123] 77.5 [42–110] 1.00 0.99–1.00 0.62
Ablett on admission:
1 34 (25.2%) 2 (4.5%) Ref.
2 83 (61.5%) 33 (75.0%) 6.76 1.90–43.12 0.011
3 18 (13.3%) 9 (20.5%) 8.50 1.94–59.82 0.010
Creatinine (μmol/L) 82.6 (± 32.3) 96.5 (± 58.9) 1.01 1.00–1.02 0.08
Platelets (× 109/L) 281.4 (± 85.1) 289.5 (± 99.6) 1.01 1.00–1.00 0.60
Potassium (mEq/L) (n = 99) 3.6 (± 0.5) 3.7 (± 0.6) 1.493 0.64–3.53 0.35
White blood count (× 109/L) (n = 100) 9.7 [7.1–11.3] 10.9 [8.6–14.2] 1.167 1.04–1.34 0.02
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β (95% CI) P value β (95% CI) P value
Female sex − 18.00 (− 26.58, − 10.33) 0.002 − 20.21 (− 23.04, − 10.13) < 0.001
Age − 0.46 (− 0.53, − 0.37) < 0.001 − 0.270 (− 0.37, − 0.26) < 0.001
Any pre-existing comorbidities − 15.28 (− 23.85, − 7.30) 0.003 − 11.36 (− 17.81, − 1.39) 0.07
Incubation period (n = 50) 0.69 (− 1.137, 1.41) 0.19 0.17 (− 0.01, 0.42) 0.31
Period of onset (n = 55) 0.06 (− 0.13, 0.10) 0.32 0.06 (− 0.22, 0.08) 0.11
Time from 1st symptom to admission 1.19 (− 1.64, 2.10) 0.19 0.70 (− 1.17, 1.25) 0.13
Difficulty breathing on admission − 9.61 (− 14.91, 8.08) 0.18 − 3.00 (− 16.57, 0.08) 0.35
Clinical Features during first 24 h of admission
Highest systolic blood pressure (mmHg)* − 0.21 (− 0.48, − 0.15) 0.07 − 0.21 (− 0.27, 0.02) 0.01
Highest heart rate (bpm) − 0.08 (− 0.38, 0.20) 0.64 − 0.08 (− 0.40, -0.01) 0.18
Heart rate range (bpm)* − 0.07 (− 0.42, 0.30) 0.70 − 0.13 (− 0.31, 0.01) 0.19
Highest temperature (°C) 5.07 (− 7.16, 8.76) 0.16 1.97 (− 13.28, 3.17) 0.23




− 6.17 (− 17.98, − 0.01) 0.27 − 3.97 (− 17.98, − 0.85) 0.82
Urine output (ml/h) 0.04 (− 0.14, 0.04) 0.20 0.01 (− 0.02, 0.03) 0.34
Creatinine (μmol/L) 0.16 (− 0.06, 0.27) 0.23 0.01 (− 0.07, 0.17) 0.93
Platelets (× 109/L) − 0.06 (− 0.10, − 0.04) 0.01 − 0.03 (− 0.08, 0.00) 0.13
1SOFA score of 0 is the baseline group
*During the first 24 h of hospital admission
**Sequential organ failure score [20]
Table 5 The association between independent features during ICU management and 25th quantile PCS at 3 months and 6 months
post discharge
3months 6months
β (95% CI) P value β (95% CI) P value
Tracheostomy required − 9.69 (− 17.61, − 2.65) 0.06 − 6.80 (− 17.31, − 0.73) 0.08
Duration tracheostomy (days) (n = 30) − 0.47 (− 2.00, − 0.34) 0.16 − 0.72 (− 1.49 − 0.38) 0.25
Mechanical ventilation required − 9.06 (− 17.56, 2.29) 0.10 − 11.36 (− 18.19, − 0.55) 0.02
Duration mechanical ventilation (days) (n = 27) − 0.33 (− 1.37, 0.08) 0.38 − 0.36 (− 1.30, − 0.22) 0.25
Autonomic nervous system disturbance − 13.52 (− 18.22, − 8.84) 0.02 − 15.65 (− 19.29, − 4.70) 0.001
Duration diazepam required (days) (n = 66) 0.51 (0.35, 0.80) 0.01 0.26 (0.10, 0.69) 0.07
Duration midazolam required (days) (n = 40) − 0.39 (− 0.87, 0.21) 0.31 − 0.61 (− 1.28, 0.02) 0.02
Duration Magnesium sulphate (days) (n = 14) 2.06 (− 7.73, 2.79) 0.10 0.73 (− 8.58, 1.57) 0.53
Duration pipecuronium (days) (n = 22) − 0.97 (− 1.15, 1.33) 0.29 − 0.69 (− 0.93, 0.90) 0.35
Ventilator-associated pneumonia* − 1.80 (0.00, − 0.153) 0.09 − 2.24 (− 17.98, − 1.92) 0.001
Bacteraemia* − 12.34 (− 28.53, − 1.00) 0.14 − 14.51 (− 25.34, − 2.13) 0.03
Urinary tract infection* − 10.46 (− 15.11, 9.99) 0.21 − 11.12 (− 17.20, − 0.44) 0.12
Any healthcare associated infection − 13.33 (− 17.92, − 3.51) 0.03 − 15.73 (− 20.04, − 4.05) 0.001
Pressure ulcer − 12.51 (− 17.98, 7.59) 0.25 − 20.28 (− 17.98, − 14.713) < 0.001
Length of ICU stay (days) − 0.52 (− 0.91, − 0.29) 0.02 − 0.56 (− 0.61, − 0.32) 0.004
Length of hospital stay (days) − 0.64 (− 0.82, − 0.30) 0.02 − 0.48 (− 0.70, − 0.34) 0.01
*Infections occurring during hospitalisation and deemed to be healthcare-related infections
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functioning. Multivariate analysis was not possible due
to small numbers in our sample; however, it is likely that
many of these features are indicative of severe disease or
prolonged treatment in ICU. Interestingly neither dur-
ation of ventilation, tracheostomy or pipecuronium ap-
peared to be strongly associated with reduced PCS at 3
or 6 months after discharge. This may indicate that other
events, such as HAI which are also associated with pro-
longation of ICU and hospital stay, are more important
determinants of outcome. Age and HAI were factors we
have previously identified as significant contributors to
increased muscle wasting during hospitalisation and
were are independent of the duration of hospital length
of stay [14]. We believe this study serves as further
evidence that preventing muscle wasting should be a
priority in improving functional outcome in critically ill
patients. HAI remains a modifiable factor associated
with this, and as we observed that even in those with
highest physical function, ventilator associated pneumo-
nia remained a predictor of PCS.
The only available Vietnamese SF-36 data is from a
group of Vietnamese migrants to Australia which cannot
be generalised to the entire Vietnamese population [24]
and the lack of data regarding the use of SF-36 in the
Vietnamese population is a significant limitation of our
study. In lieu of robust population standard normative
data, we used American population data. Additionally,
whilst we used an accepted algorithm to calculate the
PCS, it remains unclear whether other algorithms may
be superior due to assumptions about the relationship
between physical and mental health scale components—
also unknown in the Vietnamese population [25]. Our
results, however, are in agreement with previous individ-
ual scale analysis and by using a single component score
we reduce concerns related to statistical power and mul-
tiple testing [14]. By publishing data from Vietnamese
adults, we are able to contribute towards a better under-
standing of SF-36 in this population.
Conclusions
We observed that risk factors for MV, development of
ANSD and reduced physical functioning were consistent
with existing knowledge and findings in settings of low
mortality. These outcomes may therefore be suitable
endpoints against which to evaluate therapeutic inter-
ventions. Risk factors for reduced functional outcome at
3 months and 6 months post discharge suggest that
modifiable features during hospitalisation are important
determinants of long-term outcome.
Tetanus remains, however, a vaccine-preventable dis-
ease and improved preventative strategies should con-
tinue to be central to reducing morbidity and mortality
from this disease.
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